# Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia

> **NCT07240077** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Mahidol University** · enrollment: 165 (estimated)

## Conditions studied

- Bacteremia
- Streptococcus Infection

## Interventions

- **DRUG:** Beta-lactam monotherapy
- **DRUG:** Beta-lactam plus levofloxacin combination therapy

## Key facts

- **NCT ID:** NCT07240077
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07240077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07240077, "Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07240077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*